Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoconazole/Hydrocortisone vs Docetaxel/Estramustine in Prostate Cancer
NCT00027859Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Oct 2003
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in prostate cancer (PCa) comparing Ketoconazole + Hydrocortisone with Docetaxel + Estramustine (2 arms). Primary endpoint: Time to Objective Progression. Started Oct 2003; status: completed.
02
Drugs
ketoconazoledocetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00027859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00027859.